The current PYXS market cap is 197.24M. The company's latest EPS is USD -1.6648 and P/E is -2.67.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -28.39M | -37.97M | -20.95M | -18.12M | -25.35M |
Net Income | -27.67M | -36.1M | -19.24M | -15.9M | -23.05M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.88M | -12.89M | -69.72M | -123.48M | -82.2M |
Net Income | -2.77M | -12.83M | -75.98M | -120.72M | -73.79M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 223.9M | 211.38M | 182.8M | 175.23M | 186.69M |
Total Liabilities | 35.15M | 50.56M | 30.64M | 29.96M | 48.75M |
Total Equity | 188.75M | 160.82M | 152.16M | 145.28M | 137.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 19.81M | 10.15M | 280.02M | 211.38M | 173.73M |
Total Liabilities | 739k | 3.85M | 18.71M | 50.56M | 48.02M |
Total Equity | -2.87M | -15.65M | 261.31M | 160.82M | 125.7M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -71.95M | -89.34M | -26.84M | -37.87M | -55.46M |
Investing | -4.54M | -6.4M | -99.39M | -121.65M | -115.08M |
Financing | 183k | 183k | N/A | 6.13M | 5.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.24M | -10.08M | -35.33M | -89.34M | -70.71M |
Investing | N/A | -1.48M | -590k | -6.4M | -104.85M |
Financing | 21.96M | 35k | 304.04M | 183k | 5.93M |
Market Cap | 197.24M |
Price to Earnings Ratio | -2.67 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 20.41 |
Price to Book Ratio | 1.57 |
Dividend Yield | - |
Shares Outstanding | 44.32M |
Average Volume (1 week) | 444.75k |
Average Volume (1 Month) | 675.89k |
52 Week Change | 37.77% |
52 Week High | 6.85 |
52 Week Low | 1.35 |
Spread (Intraday) | 1.86 (35.84%) |
Company Name | Pyxis Oncology Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://pyxisoncology.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.